Tracking a new eye treatment for the tiniest patients
NCT ID NCT06315556
Summary
This study aims to count how many premature babies in the UK with a serious eye condition (retinopathy of prematurity) are being treated with Eylea injections using a special pediatric dosing device. Researchers will use existing hospital records to gather this information, with no extra visits or tests for the babies. The goal is to see if enough babies are receiving this treatment to justify a future, larger study on its long-term safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRETERM INFANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many locations
RECRUITINGMultiple Locations, United Kingdom
Conditions
Explore the condition pages connected to this study.